Ann: Annual Report to shareholders, page-25

Er... I'm basing this off a few things.

Last qtr we got ~350K sales and the qtr before in March we got ~435K sales purely from oral devices alone.

With all the deals we have done, I am aware that it will likely be not til Q4 2019 - Q1 2020 where it actually ramps up but still would like to see growth in that area.

AGH with 1500 patients can get ~300K rev off their oil sales.

500K probably high balling it but seems the dental oral devices is not a particularly high growth type of product....
Either way would still like a positive Q3 report... Q4 will be the big one for sure.